MiNK Therapeutics, Inc.INKTNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank80
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-2.73
↑ 81% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-14.49
Historical baseline
PeriodValueYoY Change
2024-2.73-17.6%
2023-2.32+49.5%
2022-4.60+59.7%
2021-11.42+75.7%
2020-47.08-150.5%
2019-18.80-